Case Report: Sorafenib-induced rhabdomyolysis in a post-transplant patient with acute myeloid leukemia
This case highlights that sorafenib may cause rare but severe adverse reactions, such as rhabdomyolysis. Clinicians should be vigilant about these potential adverse effects when using sorafenib and enhance patient monitoring and management.
Authors
- Lingjuan Cao
- Shang Li
- Ping Zheng (ORCID: https://orcid.org/0000-0002-6379-3015)
- Liuxian Ke
- Zijian Zhou
Institutions
- Guangdong Work Injury Rehabilitation Hospital (CN)
- Nanfang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-17
- DOI
- https://doi.org/10.3389/fonc.2026.1728530
- Primary Topic
- Muscle and Compartmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00